267 related articles for article (PubMed ID: 23205838)
21. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
22. 3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake.
Zsilla G; Hegyi DE; Baranyi M; Vizi ES
Eur J Pharmacol; 2018 Oct; 837():72-80. PubMed ID: 30172789
[TBL] [Abstract][Full Text] [Related]
23. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
O'Dell SJ; Weihmuller FB; Marshall JF
J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
[TBL] [Abstract][Full Text] [Related]
24. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
25. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
Rizzo FR; Federici M; Mercuri NB
Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
[TBL] [Abstract][Full Text] [Related]
26. Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury.
Eisch AJ; Marshall JF
Synapse; 1998 Dec; 30(4):433-45. PubMed ID: 9826235
[TBL] [Abstract][Full Text] [Related]
27. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice.
Achat-Mendes C; Ali SF; Itzhak Y
Neuropsychopharmacology; 2005 Jun; 30(6):1128-37. PubMed ID: 15688084
[TBL] [Abstract][Full Text] [Related]
29. Dose and time-dependent selective neurotoxicity induced by mephedrone in mice.
Martínez-Clemente J; López-Arnau R; Abad S; Pubill D; Escubedo E; Camarasa J
PLoS One; 2014; 9(6):e99002. PubMed ID: 24892744
[TBL] [Abstract][Full Text] [Related]
30. Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity.
Kuhn DM; Francescutti-Verbeem DM; Thomas DM
Ann N Y Acad Sci; 2008 Oct; 1139():118-26. PubMed ID: 18991856
[TBL] [Abstract][Full Text] [Related]
31. Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.
Peraile I; Torres E; Mayado A; Izco M; Lopez-Jimenez A; Lopez-Moreno JA; Colado MI; O'Shea E
Br J Pharmacol; 2010 Jan; 159(1):201-11. PubMed ID: 20015297
[TBL] [Abstract][Full Text] [Related]
32. Neurotoxicity Induced by Mephedrone: An up-to-date Review.
Pantano F; Tittarelli R; Mannocchi G; Pacifici R; di Luca A; Busardò FP; Marinelli E
Curr Neuropharmacol; 2017; 15(5):738-749. PubMed ID: 27908258
[TBL] [Abstract][Full Text] [Related]
33. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines.
Thomas DM; Dowgiert J; Geddes TJ; Francescutti-Verbeem D; Liu X; Kuhn DM
Neurosci Lett; 2004 Sep; 367(3):349-54. PubMed ID: 15337264
[TBL] [Abstract][Full Text] [Related]
34. Methamphetamine and MDMA (ecstasy) neurotoxicity: 'of mice and men'.
Itzhak Y; Achat-Mendes C
IUBMB Life; 2004 May; 56(5):249-55. PubMed ID: 15370888
[TBL] [Abstract][Full Text] [Related]
35. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
Schmidt CJ; Black CK; Taylor VL
Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
[TBL] [Abstract][Full Text] [Related]
36. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
[TBL] [Abstract][Full Text] [Related]
37. The Effects of Exposure to Mephedrone During Adolescence on Brain Neurotransmission and Neurotoxicity in Adult Rats.
Kamińska K; Noworyta-Sokołowska K; Górska A; Rzemieniec J; Wnuk A; Wojtas A; Kreiner G; Kajta M; Gołembiowska K
Neurotox Res; 2018 Oct; 34(3):525-537. PubMed ID: 29713996
[TBL] [Abstract][Full Text] [Related]
38. Effects of glutamate antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine-induced striatal dopamine release in vivo.
Finnegan KT; Taraska T
J Neurochem; 1996 May; 66(5):1949-58. PubMed ID: 8780022
[TBL] [Abstract][Full Text] [Related]
39. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
Itzhak Y; Gandia C; Huang PL; Ali SF
J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
[TBL] [Abstract][Full Text] [Related]
40. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK
Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
